corporate profile - alinamin pharma

8
CORPORATE PROFILE 2021

Upload: others

Post on 12-Feb-2022

6 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: CORPORATE PROFILE - Alinamin Pharma

CORPORATEPROFILE

2021

Page 2: CORPORATE PROFILE - Alinamin Pharma

Message

Takeda Consumer Healthcare Becomes

Alinamin Pharmaceutical

On April 1, 2021, Takeda Consumer Healthcare changed its

name to Alinamin Pharmaceutical.

This name change is affirmation of our future-oriented

approach and commitment to taking on new challenges.

Our dedication to helping all our customers lead healthy and

rewarding lives remains the same, and all established

production processes, manufacturing centers, and

manufacturing technicians for all products remain unchanged.

We thank you for your ongoing support as we continue to

deliver excellent products and reliable information.

Our new corporate symbol expresses two significant

concepts: our future-focused development and the

maintenance of our existing principles.

Future-focused development : a renewed future-

oriented approach and spirit to take on challenges.

Maintaining existing principles: a steadfast

commitment to our convictions (Integrity, Fairness,

Honesty and Perseverance) and to our customers.

The three points of the triangle represent our

challenges, convictions, and customer commitment.

The triangle in the center of the Alinamin

Pharmaceutical ‘A’ represents our future-oriented

approach.

The new corporate symbol embodies the promise

from our company to all stakeholders, beginning

with our customers.

Corporate Symbol

• Symbolizes the ‘A’ of Alinamin Pharmaceutical

• Embodies the promise we make to our stakeholders

• The white pathway represents our commitment to mutual trust

Future-oriented approach

Challenges Customer commitment

Convictions (Integrity・Fairness・Honesty・Perseverance)

Overall Concept

Page 3: CORPORATE PROFILE - Alinamin Pharma

Our Products

Alinamin® MEDICAL Balance Alinamin® ZERO7 Alinamin® V Alinamin® A Alinamin® EX PLUS Alinamin® EX PLUSα Alinamin® EX GOLD

BENZA BLOCKⓇ S PREMIUM BENZA BLOCKⓇ L PREMIUM BENZA BLOCKⓇ IP PREMIUMTAKEDA KAMPO

BENPIYAKU

Bio-Three® Hi Tablet HICEEⓇ 1000 Midori no ShukanⓇ

Barley Young Leaf and Kale

Midori no ShukanⓇ

Bifidobacterium

MytearⓇ ALPITATTO EX α New MytearⓇ CL-s NICORETTE® Cool Mint BORRAGINOL® A CHUNYUNANKO

Pouch Type Bottle Type Bottle Type Vitamin Supplement Vitamin Supplement Vitamin Supplement Vitamin Supplement

Cold Remedy Cold Remedy Laxative Intestinal Regulation Drug Vitamin Supplement Dietary Supplement

Ophthalmic Medication Stop Smoking Aid Anti-hemorrhoid Drug

SHIN CALCICHEW🄬 D3

Calcium Supplement

BORRAGINOL® M ZAZAITYLENOL® A

Pain Reliever/Fever Reducer

The product range will remain the same after April 1, 2021.

Cold Remedy

Anti-hemorrhoid DrugOphthalmic Medication

Dietary Supplement

Page 4: CORPORATE PROFILE - Alinamin Pharma

Our Major Business Partners and Products

Amato PharmaceuticalProducts, Ltd.

Johnson & Johnson K.K.

Senju PharmaceuticalCo., Ltd.

Nihon PharmaceuticalCo., Ltd.

Borraginol series (anti-hemorrhoid drug)

Nicorette series (stop smoking aid)

Aneton series (antitussives and expectorants, rhinitis

medicine)

Terra-cortril NANKO a (dermatological medicine)

Terramycin NANKO a (dermatological medicine)

Tylenol A (antipyretic analgesic)

Mytear series (eye drops, contact lens solution)

Osvan series (bactericidal disinfectant)

Page 5: CORPORATE PROFILE - Alinamin Pharma

Alinamin Pharma Tech Co., Ltd. was established

in 1980 as the leading manufacturer of OTC drugs

marketed by Alinamin Pharmaceutical Co., Ltd.

2-21 Osadano-cho, Fukuchiyama-shi, Kyoto

620-0853, Japan

Subsidiary

Group Company

Page 6: CORPORATE PROFILE - Alinamin Pharma

Company Facts

Company Name

Alinamin Pharmaceutical Co., Ltd.

President and CEO

Hideshi Honda

Date Established

April 15, 2016

Business Started

April 1, 2017

Capital

490 million yen

Head Office

Tekko Building 23F,

8-2 Marunouchi 1-chome, Chiyoda-ku,

Tokyo 100-0005, Japan

Offices

Total of 8 offices

Fiscal Year End

March 31

Scope of Business

Research & development, manufacturing,

sales and marketing of over-the-counter

products, quasi-drugs, etc.

Page 7: CORPORATE PROFILE - Alinamin Pharma

Offices

Head Office

Tekko Building 23F,

8-2 Marunouchi 1-chome, Chiyoda-ku,

Tokyo 100-0005

TEL: +81-3-6212-8501 FAX: +81-3-6212-8695

Osaka Office

Takeda Midosuji Building,

1-1 Doshomachi 4-Chome, Chuo-ku,

Osaka-shi, Osaka 541-0045

Sapporo Office

FWD Sapporo Building 9F,

4 Kitaichijo-Nishi 13-chome, Chuo-ku,

Sapporo-shi, Hokkaido 060-0001

Sendai Office

Kashima Jozenji Building 7F,

18-21 Honcho 2-chome, Aoba-ku,

Sendai-shi, Miyagi 980-0014

Nagoya Office

Nagoya Center Building 7F,

2-13 Nishiki 2-chome, Naka-ku,

Nagoya-shi, Aichi 460-0003

Hiroshima Office

Building Hirotake Heiwa Odori 2F,

1-25 Komachi, Naka-ku,

Hiroshima-shi, Hiroshima 730-0041

Fukuoka Office

Fukuoka Showadori Building 4F,

9-12 Shimokawabata, Hakata-ku,

Fukuoka-shi, Fukuoka 812-0027

Juso CMC Center

17-85 Jusohonmachi, 2-chome, Yodogawa-ku,

Osaka-shi, Osaka 532-0024

Page 8: CORPORATE PROFILE - Alinamin Pharma

Tekko Building 23F,

8-2 Marunouchi 1-chome, Chiyoda-ku,

Tokyo 100-0005, Japan

TEL: +81-3-6212-8501

FAX: +81-3-6212-8695

www. alinamin-pharma.co.jp/en/

As of April 2021